Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, July 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
PGDx Raises $2.8 Million and Launches its METDetect™ Assay
Thursday, April 03, 2014
First-in-class CLIA assay for detection of tumor-specific gene amplifications using circulating cell-free DNA.

Cancer Genetics Expands BioDiscovery's Nexus Copy Number Platform
Thursday, April 03, 2014
Expansion to identify novel biomarkers predictive of cancer outcomes.

Physiologically Relevant Cell Culture Handbook
Tuesday, April 01, 2014
48-page handbook is also a resource for neuroscience, drug discovery and regenerative medicine applications.

Promega Introduces Maxwell 16 LEV RNA FFPE Kit
Tuesday, April 01, 2014
New kit provides high yield, pure and amplifiable RNA from FFPE mammalian tissue samples.

Identifying Epigenetic Biomarkers for Prostate Cancer
Tuesday, April 01, 2014
IDT qPCR assays and probes facilitate the development of predictive epigenetic biomarkers.

EKF Molecular Highlights Ultra-Sensitive Cancer Mutation Detection Kits
Wednesday, March 26, 2014
PointMan™ DNA-enrichment kits offer unrivalled cancer gene detection in whole blood.

New Updates to Leading aCGH Data Analysis Software
Wednesday, March 26, 2014
OGT releases new CytoSure™ Interpret Software to enhance CNV detection.

Integrated DNA Technologies Advances Human Health and Clinical Research
Monday, March 24, 2014
Company extends its portfolio of NGS panels with the addition of the xGen® Inherited Disease and Pan-Cancer Panels.

ChromaTrap Receives Positive Commentary in Cited Research
Thursday, March 20, 2014
Researchers cite how using the fast, sensitive ChIP technology has benefited their research.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 2494
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv